持续加大AI研发投入 开立医疗推出多款AI医疗新品

Core Viewpoint - The company, Kaili Medical, has been investing in AI technology research for nearly a decade, resulting in the development of multiple AI-enabled products that enhance diagnostic accuracy and efficiency in medical devices [1][2]. Group 1: AI Technology Integration - Kaili Medical's AI strategy focuses on integrating AI into medical devices rather than pursuing standalone "AI+" or "Internet+" models, ensuring that AI enhances ultrasound and endoscopy equipment [1]. - The S-Fetus technology, developed by Kaili Medical, is the first domestic deep learning-based obstetric ultrasound detection technology, achieving a standard plane recognition rate of over 90% and reducing examination time by 50% [2]. Group 2: Clinical Impact - Early detection of gastrointestinal tumors significantly increases survival rates, with over 90% for early-stage patients, while late-stage patients have survival rates below 25% [2]. - The AI endoscope developed by Kaili Medical functions similarly to a GPS, guiding doctors and providing alerts to improve diagnostic accuracy and reduce missed diagnoses [3]. Group 3: Product Development - Kaili Medical plans to launch a new series of products featuring the iEndo® medical endoscope system platform, which utilizes an innovative multi-core heterogeneous imaging architecture for enhanced computational capabilities [3].